Literature DB >> 12957272

Intensity-modulated stereotactic radiotherapy vs. stereotactic conformal radiotherapy for the treatment of meningioma located predominantly in the skull base.

Brigitta G Baumert1, Ian A Norton, J Bernard Davis.   

Abstract

PURPOSE: This study evaluates a possible advantage of intensity-modulated stereotactic radiotherapy (IMSRT) over stereotactic conformal radiotherapy (SCRT) in the treatment of lesions in the base of the skull. METHODS AND MATERIALS: Ten patients (7 with a skull base meningioma) planned for routine SCRT were replanned for IMSRT. The criteria for comparison were the same for both methods: optimal dose to the planning target volume (PTV) and optimal sparing of the organs at risk (OAR). For SCRT, sparing of OAR was achieved by conformal avoidance using 5-6 fields. The IMSRT inverse planning process used optimized OAR sparing through user-defined dose constraints. Dose to the PTV and OAR were assessed by dose-volume histograms, maximum dose, 2 conformity indices, and volumes of relevant isodoses.
RESULTS: The conformity index is consistently higher for IMSRT, the largest improvement being for the multifocal and irregular cases. Volumes of the 90% and 80% isodoses were smaller for IMSRT, whereas the volume of the 30% isodose was larger for IMSRT in 6 cases. The maximum dose was consistently higher for IMSRT (mean values 102% and 108% for SCRT and IMSRT, respectively). Sparing of OAR was better with IMSRT, especially for those OARs situated in or near a concave PTV.
CONCLUSIONS: In terms of PTV coverage, there is an advantage in using IMSRT for all target shapes, but especially for irregular and concave targets. The dose to OAR is lower with IMSRT, although the volume of normal tissue receiving a low dose can be larger than for SCRT.

Entities:  

Mesh:

Year:  2003        PMID: 12957272     DOI: 10.1016/s0360-3016(03)00587-x

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

1.  Impact of the high-definition multileaf collimator on linear accelerator-based intracranial stereotactic radiosurgery.

Authors:  J A Tanyi; C M Kato; Y Chen; Z Chen; M Fuss
Journal:  Br J Radiol       Date:  2010-10-05       Impact factor: 3.039

Review 2.  New prospects for management and treatment of inoperable and recurrent skull base meningiomas.

Authors:  Mahlon D Johnson; Burak Sade; Michael T Milano; Joung H Lee; Steven A Toms
Journal:  J Neurooncol       Date:  2007-07-12       Impact factor: 4.130

3.  Overall and progression-free survival and visual and endocrine outcomes for patients with parasellar lesions treated with intensity-modulated stereotactic radiosurgery.

Authors:  Randy L Jensen; Peter R Jensen; Annabelle F Shrieve; Lisa Hazard; Dennis C Shrieve
Journal:  J Neurooncol       Date:  2010-05-12       Impact factor: 4.130

4.  Review of photon and proton radiotherapy for skull base tumours.

Authors:  Piero Fossati; Andrea Vavassori; Letizia Deantonio; Eleonora Ferrara; Marco Krengli; Roberto Orecchia
Journal:  Rep Pract Oncol Radiother       Date:  2016-04-16

5.  Stereotactic radiosurgery of intracranial tumors: a comparison of intensity-modulated radiosurgery and dynamic conformational arc.

Authors:  Marcos Dellaretti; Júlio Leonardo Barbosa Pereira; Eduardo Tagawa; Mariana Pedrini
Journal:  J Radiosurg SBRT       Date:  2012

Review 6.  State-of-the-art treatment alternatives for base of skull meningiomas: complementing and controversial indications for neurosurgery, stereotactic and robotic based radiosurgery or modern fractionated radiation techniques.

Authors:  Stephanie E Combs; Ute Ganswindt; Robert L Foote; Douglas Kondziolka; Jörg-Christian Tonn
Journal:  Radiat Oncol       Date:  2012-12-29       Impact factor: 3.481

Review 7.  Meningioma: current treatment options and future directions.

Authors:  Kevin P McMullen; Volker W Stieber
Journal:  Curr Treat Options Oncol       Date:  2004-12

8.  Single fraction radiosurgery using Rapid Arc for treatment of intracranial targets.

Authors:  Hendrik A Wolff; Daniela M Wagner; Hans Christiansen; Clemens F Hess; Hilke Vorwerk
Journal:  Radiat Oncol       Date:  2010-09-13       Impact factor: 3.481

9.  [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning.

Authors:  Barbara Gehler; Frank Paulsen; Mehmet O Oksüz; Till-Karsten Hauser; Susanne M Eschmann; Roland Bares; Christina Pfannenberg; Michael Bamberg; Peter Bartenstein; Claus Belka; Ute Ganswindt
Journal:  Radiat Oncol       Date:  2009-11-18       Impact factor: 3.481

10.  Efficacy and Tolerance of Intensity Modulated Radiation Therapy for Skull Base Meningioma.

Authors:  Youssef Brahimi; Delphine Antoni; Robin Srour; François Proust; Alicia Thiery; Pierre Wagner; Georges Noel
Journal:  Adv Radiat Oncol       Date:  2019-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.